Tevogen TVGN 深 滬
等待開盤 10-29 09:30:00 美东时间
6.24
-0.040
-0.64%
華盛通- 最 高7.00
- 今 開6.11
- 成交量 2.15万股
- 最 低 6.00
- 昨 收 6.28
- 總市值 4063.20万
- 52周最高 25.115
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 3.6364
- 委 比 -81.22%
- 總股本 651.15万
- 歷史最高 1054.50
- 量 比 1.18
- 振 幅 15.92%
- 歷史最低 3.6364
- 每 手 1
- 風險率 6.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TVGN收涨0.48%，成交额3.31万美元
10月28日，TVGN（TVGN）收涨0.48%，报6.28美元，成交额3.31万美元，市值4089.25万美元。 行情数据 • 开盘价：6.12美元 • 最高...
10-28 07:31
TVGN收跌4.11%，成交额26.1万美元
10月24日，TVGN（TVGN）收跌4.11%，报6.53美元，成交额26.1万美元，市值4252.04万美元。 行情数据 • 开盘价：6.81美元 • 最高...
10-24 07:31
TVGN收跌0.14%，成交额1.6万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:31
Tevogen Signs Letter Of Intent To Evaluate A Potential Transaction With HRK Healthcare; Sees Path To Realizing ~$100M In Combined Annual Revenue
Tevogen Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive...
10-09 02:12
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
Tevogen Inc. has signed a non-exclusive, non-binding Letter of Intent with HRK Healthcare LLC to evaluate a potential transaction that could expand its healthcare infrastructure capabilities and support its evolution into a revenue-generating healthcare enterprise. The transaction, if consummated, could potentially pave the way for Tevogen to achieve approximately $100 million in combined annual revenue. The proposed deal remains subject to due d...
10-08 18:10
Tevogen Bio grants major performance-based executive stock awards
Tevogen Bio Holdings ( ($TVGN) ) has provided an update. On September 14, 2026,...
09-17 05:27
Tevogen Bio regains Nasdaq listing compliance status
Tevogen Bio Holdings ( ($TVGN) ) has shared an announcement. On September 9, 20...
09-10 21:47
Tevogen Bio becomes Tevogen Inc.
Tevogen Bio Holdings Inc. (TVGN) announced that it will operate under the name Tevogen Inc., following approval by its board of directors. The name change reflects Tevogen's ongoing evolution into a h...
07-29 21:12
Tevogen To Operate Under Tevogen Inc. Name, Effective July 30
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that it will operate under the name Tevogen Inc., following approval by its Board of Directors. The name change reflects Tevogen's ongoing evolution into a healthcare enterprise where science, technology, and patient c...
07-29 20:03
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
Tevogen Bio Holdings Inc. has changed its name to Tevogen Inc., reflecting its evolution into a healthcare enterprise focused on integrating science, technology, and patient care. The name change will take effect on July 30, 2026, with no changes to its stock ticker symbols "TVGN" and "TVGNW." CEO Ryan Saadi emphasized the company's mission to create an integrated healthcare model to reduce medication costs and expand patient access.
07-29 12:00
